Michael M. Abecassis
Insider Reports History
- Location
- Las Vegas, NV
- Signature
- /s/ Jeffrey D. Cohan, as Attorney-in-Fact for Michael M. Abecassis
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Michael M. Abecassis:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| PharmaCyte Biotech, Inc. | Director | Common Stock | 22,292 | $22,737 | $1.02 | 12 Dec 2025 | Direct |
| PharmaCyte Biotech, Inc. | Director | Common Stock | 800 | $680 | $0.8500 | 25 Apr 2025 | By Transplant Consulting LLC |
| PharmaCyte Biotech, Inc. | Director | Stock Option (Right to Buy) | 119,170 | 31 Mar 2026 | Direct |
Insider Reports Filed by Michael M. Abecassis
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| PMCB | PharmaCyte Biotech, Inc. | 31 Mar 2026 | 1 | $0 | 4 | Director | 02 Apr 2026, 18:16 |
| PMCB | PharmaCyte Biotech, Inc. | 25 Apr 2025 | 3 | -$17,212 | 4 | Director | 12 Dec 2025, 17:06 |
| PMCB | PharmaCyte Biotech, Inc. | 30 Apr 2024 | 1 | $0 | 4 | Director | 17 Jul 2024, 16:58 |
| PMCB | PharmaCyte Biotech, Inc. | 20 Nov 2023 | 1 | $0 | 4 | Director | 22 Nov 2023, 17:00 |
| PMCB | PharmaCyte Biotech, Inc. | 10 Aug 2021 | 0 | $0 | 3 | Director | 20 Aug 2021, 20:35 |